(Z)-RG-13022 is a tyrosine kinase (TK) inhibitor that preferentially inhibits EGFR TK activity and suppresses EGF-stimulated growth of cultured cells; it exhibits an IC50 of 11 μM for DNA synthesis in HN5 cells, over 3-fold more potent than (E)-RG-13022 (IC50 = 38 μM); it can be used in the study of breast cancer cells.